Pricing

Log inSign up

VistaGen Therapeutics

4 followers

‌

VistaGen Therapeutics (NASDAQ: VTGN) is a clinical-stage biopharmaceutical company developing new generation medicines for multiple CNS diseases and disorders with high unmet need.

Industries

Education, Pharmaceutical

Headquarters

South San Francisco, United States

Employees

11-50

Links

Org chart

Shawn K. Singh
CEO & Director
Collapse
Reid Adler
Chief Legal Officer
Cindy Anderson
CFO
Mark J. Ginski
SVP, Head of CMC
Allen Cato III
SVP, Development Operations
Trisha Fitzmaurice
SVP, Human Resources
Joshua Prince
VP, Strategic Insights & Analytics
Louis Monti
VP, Translational Medicine
Mark Flather
VP, Investor Relations
Mark A. McPartland
VP, Corporate Development
Ester Salmán
VP, Clinical Research
Edith Perez
Senior Executive Assistant

Board & advisors

Jon S. Saxe
Chairman
Ann M. Cunningham
Member, Board Of Directors
Jerry Gin
Director
BU
Brian J. Underdown
Director
Joanne Curley
Director
Mary L. Rotunno
Director
MF
Maurizio Fava
Chairman
GK
Gordon Keller
Advisor
TL
Thomas Laughren
Advisor
ML
Michael Liebowitz
Advisor
SM
Sanjay Mathew
Advisor
GS
Gerard Sanacora
Advisor
MW
Mark Wallace
Advisor

Teams

+1

Leadership Team

5 people · 0 jobs

+2

Clinical and Medical Team

6 people · 0 jobs

Legal and Compliance

3 people · 0 jobs

HS
KC

Project Management

3 people · 0 jobs

Regulatory and Quality Affairs

2 people · 0 jobs

Offices

Similar companies

Arthritis Knee Pain Centers

2 followers

Cellares

4 followers

Bristol-Myers Squibb

250 followers

Springside Chestnut Hill Academy

35 followers

2U

22 followers

Chicago Public Schools

19 followers

NYU Langone Health

24 followers

General Assembly

12 followers

SCORE Mentors

10 followers

West Pharmaceutical Services

8 followers

Great Minds

8 followers

Explore companies